PDCD1 and neoplasm: The results showed that aurora kinase inhibitors reprogram the expression of TIP gene signature and thus promote effective T-cell infiltration into the tumor microenvironment, significantly improving anti-programmed cell death 1 (PD-1) efficacy in preclinical models (51).